Design that survives the review process.
Pharmaceutical website design for corporate sites, product ranges and professional areas, built around how medical, regulatory and marketing teams actually review and approve content. The structure has to hold when a claim is removed, a market changes or a product becomes unavailable.
Design for a regulated company is structural before it is visual. The same page serves patients and prescribers, the same product is presented differently by market, and every line of copy passes a review the design team does not control.
An access and content map, information architecture validated with your team, a component system with real states, responsive behaviour for every component, and the front-end implementation that goes with it.
We take the design through to front-end implementation ourselves, so the structural decisions around states and multilingual content survive the handoff instead of getting lost in a file passed to someone else.
What our pharmaceutical website design work has had to accommodate structurally.
Every company asks for a new website. What pharmaceutical website design has to resolve underneath is completely different in each case.
What comes up in almost every first design conversation.
Three things. Content passes a review the agency does not control, so the structure has to survive edits. The same product may be shown differently, or not at all, depending on the market. And the site usually serves patients and healthcare professionals at once, which has to be resolved in the architecture rather than with a disclaimer.
Yes, and usually we do. Most groups have a global identity and the local team has limited freedom. Our job then is to build the digital system on top of it: components, hierarchies and states that the guidelines never covered because they were written for print.
We design around the medical-review workflow rather than against it. Content blocks can be swapped without breaking layout, approved and editable areas are kept clearly separated in the page structure, and a rejected claim never forces a redesign of the page it sits on — only the block in question needs to change, and the rest of the layout stays intact.
Yes, and it is usually one of the main reasons companies choose us over a template site. We build a component-based backend so your local marketing team can create and update pages, swap approved content blocks and launch in-market variants without needing a developer for routine changes. The components themselves stay inside the structure and brand guidelines already approved, so day-to-day editing cannot break the design or bypass what medical review signed off on.
Design usually arrives with a migration, a multilingual rollout or an accessibility review attached. These are the services it most often sits with.
A corporate site, a professional area, a product range or a redesign. Tell us the context and we will tell you how we would approach the pharmaceutical website design.